Genetic Evaluation of Localized Prostate Cancer in a Cohort of Forty Patients: Gain Of Distal 8q Discriminates Between Progressors and Nonprogressors

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Laboratory Investigation

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.LAB.0000074889.76221.49PMID 12808114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours

  2005cited by this paper
• Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer.

  2002influential reference
• Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.

  2001cited by this paper
• Incidence of cancer in the Netherlands.

  2001cited by this paper
• LAPSER1: a novel candidate tumor suppressor gene from 10q24.3

  2001cited by this paper
• Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.

  2001cited by this paper
• Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.

  2001cited by this paper
• Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.

  2001cited by this paper
• Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.

  2000cited by this paper
• Deletion at 13q21 is associated with aggressive prostate cancers.

  2000cited by this paper
• Identification of Genetic Markers for Prostatic Cancer Progression

  2000cited by this paper
• High frequency of deletion on chromosome 9p21 may harbor several tumor‐suppressor genes in human prostate cancer

  1999cited by this paper
• Universal linkage system: An improved method for labeling archival DNA for comparative genomic hybridization

  1999cited by this paper
• Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.

  1999cited by this paper
• Chromosomal clues to the development of prostate tumors

  1999cited by this paper
• Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

  1999cited by this paper
• Genetic pattern of prostate cancer progression

  1999cited by this paper
• Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer

  1999influential reference
• Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals

  1999cited by this paper
• Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.

  1999cited by this paper
• Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

  1999cited by this paper
• Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non‐persistent and metastatic tumours

  1998cited by this paper
• Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

  1998cited by this paper
• Genetic alterations in hormone-refractory recurrent prostate carcinomas.

  1998cited by this paper
• Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer

  1998cited by this paper
• Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions

  1997cited by this paper
• Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.

  1997cited by this paper
• Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

  1997cited by this paper
• Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer

  1997cited by this paper
• Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

  1996cited by this paper
• Development of seven new human prostate tumor xenograft models and their histopathological characterization.

  1996cited by this paper
• Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.

  1996cited by this paper
• Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.

  1996influential reference
• Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

  1996cited by this paper
• Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

  1996cited by this paper
• Distinct regions of allelic loss on 13q in prostate cancer.

  1996cited by this paper
• The role of increasing detection in the rising incidence of prostate cancer.

  1995cited by this paper
• DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.

  1995cited by this paper
• Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

  1995cited by this paper
• Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.

  1994cited by this paper
• Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.

  1994cited by this paper
• Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.

  1994cited by this paper
• Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

  1993cited by this paper
• Cytogenetic analysis of 57 primary prostatic adenocarcinomas

  1992cited by this paper
• Histologic grading of prostate cancer: a perspective.

  1992cited by this paper
• Carcinoma of the prostate.

  1991cited by this paper
• Cytogenetic evaluation of 20 cultured primary prostatic tumors.

  1991cited by this paper
• TNM Atlas

  1989cited by this paper

• Genomic analysis in chemotherapy-naïve prostate cancer prior to PSMA-targeted treatment.

  2026cites this paper
• ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer

  2024cites this paper
• Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer

  2015cites this paper
• Significance of S 100 A 4 expression in prostatic adenocarcinoma

  2015cites this paper
• Characterization of fusion oncogenes involving the ETS family of transcription factors and their role as diagnostic and prognostic markers in prostate cancer

  2014cites this paper
• Molecular Genetics and Cancer Biology

  2012cites this paper
• Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis

  2012cites this paper
• The role of 8q amplification and microRNAs in prostate cancer

  2012cites this paper
• Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial‐to‐mesenchymal transition

  2011cites this paper
• Cytogenomic aberrations associated with prostate cancer.

  2011cites this paper
• Chromosome 8 markers of metastatic prostate cancer in African American men: Gain of the MIR151 gene and loss of the NKX3‐1 gene

  2011cites this paper
• Two New Cases of Polysomy 13 in Canine Prostate Cancer

  2010cites this paper
• Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer

  2009cites this paper
• The Prostate 68 : 1496 ^ 1509 ( 2008 ) SimultaneouslyDetectionofGenomic and ExpressionAlterations in ProstateCancer UsingcDNAMicroarray

  2008cites this paper
• Aberrationen von Chromosom 8p im Prostatakarzinom: Von Gendosis- über Expressionsveränderungen zu neuen Kandidatengenen

  2008cites this paper
• ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.

  2008cites this paper
• Gain of Chromosome 8q: A Potential Prognostic Marker in Resectable Adenocarcinoma of the Pancreas?

  2007cites this paper
• Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.

  2007cites this paper
• Chromosomal aberrations in prostate cancer.

  2007cites this paper
• Molecular genetics of prostate cancer: clinical translational opportunities.

  2007cites this paper
• Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer

  2007cites this paper
• Somatic Alterations in Prostate Cancer Progression

  2007cites this paper
• Charakterisierung einer neuen Amplifikationseinheit auf Chromosom 3q25-q26 beim Prostatakarzinom mit Hilfe molekular-zytogenetischer und quantitativer PCR-Techniken

  2007influential citation
• A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.

  2007cites this paper
• Statistical recombinant mapping in extended high‐risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb

  2007cites this paper
• Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas

  2006cites this paper
• The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study

  2006cites this paper
• Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma.

  2006cites this paper
• 8q Gain Is an Independent Predictor of Poor Survival in Diagnostic Needle Biopsies from Prostate Cancer Suspects

  2006cites this paper
• Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array

  2006cites this paper
• Statistical dissection of genetic pathways involved in prostate carcinogenesis

  2006cites this paper
• Amplification and Overexpression of ERBB2, uPA, TRPS1, EIF3S3 and MYC Genes in Prostate Cancer

  2006cites this paper
• Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer

  2006cites this paper
• Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.

  2006cites this paper
• Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence

  2006cites this paper
• High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer

  2005cites this paper
• Construction and application of a full‐coverage, high‐resolution, human chromosome 8q genomic microarray for comparative genomic hybridization

  2005cites this paper
• Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

  2005cites this paper
• Comparative genomic hybridization in four angiosarcomas of the female breast.

  2005cites this paper
• Using Comparative Genomics to Leverage Animal Models in the Identification of Cancer Genes. Examples in Prostate Cancer.

  2005cites this paper
• Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer

  2004cites this paper
• Surgical margin and gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance

  2004cites this paper
• Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics.

  2004influential citation